E-LIB Suche - Ergebnisse für: Isa, Reiko

1

Prognostic model for relapsed/refractory transplant-ineligi..:

Ide, Daisuke ; Fujino, Takahiro ; Kobayashi, Tsutomu...
International Journal of Hematology. 119 (2024) 6 - p. 697-706 , 2024

Link: https://doi.org/10.1007/..

2

Negative impact of immunoparesis in response to anti-SARS-C..:

Onishi, Akio ; Matsumura-Kimoto, Yayoi ; Mizutani, Shinsuke...
International Journal of Hematology. 119 (2023) 1 - p. 50-61 , 2023

Link: https://doi.org/10.1007/..

3

miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signa..:

Kawaji‐Kanayama, Yuka ; Tsukamoto, Taku ; Nakano, Masakazu...
Cancer Science. 115 (2023) 2 - p. 452-464 , 2023

Link: https://doi.org/10.1111/..

4

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL ..:

Kawaji-Kanayama, Yuka ; Tsukamoto, Taku ; Nakano, Masakazu...
HemaSphere. 7 (2023) S3 - p. e0595036 , 2023

Link: https://doi.org/10.1097/..

5

Triple targeting of RSK, AKT, and S6K as pivotal downstream..:

Katsuragawa‐Taminishi, Yoko ; Mizutani, Shinsuke ; Kawaji‐Kanayama, Yuka...
Cancer Science. 114 (2023) 12 - p. 4691-4705 , 2023

Link: https://doi.org/10.1111/..

6

Tumour‐derived exosomes promote the induction of monocytic ..:

Mizuhara, Kentaro ; Shimura, Yuji ; Tsukamoto, Taku...
British Journal of Haematology. 203 (2023) 3 - p. 426-438 , 2023

Link: https://doi.org/10.1111/..

7

Clinical Implication of the Effect of the Production of Neu..:

Maekura, Chika ; Muramatsu, Ayako ; Nagata, Hiroaki...
Infection and Drug Resistance. 15 (2022) - p. 2723-2728 , 2022

Link: https://doi.org/10.2147/..

8

Clinical impacts of frailty, poor performance status, and a..:

Kawaji-Kanayama, Yuka ; Muramatsu, Ayako ; Sasaki, Nana...
International Journal of Hematology. 115 (2022) 3 - p. 350-362 , 2022

Link: https://doi.org/10.1007/..

9

Watchful waiting is an acceptable treatment option for asym..:

Mizuhara, Kentaro ; Kobayashi, Tsutomu ; Nakao, Mitsushige...
Cancer Medicine. 12 (2022) 3 - p. 3134-3144 , 2022

Link: https://doi.org/10.1002/..

10

The Rationale for the Dual-Targeting Therapy for RSK2 and A..:

Isa, Reiko ; Horinaka, Mano ; Tsukamoto, Taku...
International Journal of Molecular Sciences. 23 (2022) 6 - p. 2919 , 2022

Link: https://doi.org/10.3390/..

11

Combination of Bone Marrow Biopsy and Flow Cytometric Analy..:

Okamoto, Haruya ; Uoshima, Nobuhiko ; Muramatsu, Ayako...
Diagnostics. 11 (2021) 9 - p. 1724 , 2021

Link: https://doi.org/10.3390/..

12

EWSR1 overexpression is a pro-oncogenic event in multiple m..:

Nishiyama, Daichi ; Chinen, Yoshiaki ; Isa, Reiko...
International Journal of Hematology. 113 (2020) 3 - p. 381-394 , 2020

Link: https://doi.org/10.1007/..

13

Toward further simplification of elotuzumab therapy by subc..:

Shimura, Yuji ; Tsukamoto, Taku ; Yamaguchi, Junko...
International Journal of Hematology. 112 (2020) 3 - p. 427-428 , 2020

Link: https://doi.org/10.1007/..

14

Serine‐227 in the N‐terminal kinase domain of RSK2 is a pot..:

Matsumura‐Kimoto, Yayoi ; Tsukamoto, Taku ; Shimura, Yuji...
Cancer Medicine. 9 (2020) 14 - p. 5185-5199 , 2020

Link: https://doi.org/10.1002/..

15

Aberrant BUB1 Overexpression Promotes Mitotic Segregation E..:

Fujibayashi, Yuto ; Isa, Reiko ; Nishiyama, Daichi...
Cancers. 12 (2020) 8 - p. 2206 , 2020

Link: https://doi.org/10.3390/..